Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Sanofi-Aventis Australia
Administration route
Subcutaneous injection
Vaccine group
Monovalent vaccines
Description:
Registered for use in people aged ≥2 months.
Inactivated poliovirus (IPV) vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 40 D-antigen units inactivated poliovirus type 1 (Mahoney)
- 8 D-antigen units inactivated poliovirus type 2 (MEF-1)
- 32 D-antigen units inactivated poliovirus type 3 (Saukett)
- 2–3 µL 2-phenoxyethanol
- 2–20 µg formaldehyde
- polysorbate 80
Also contains traces of:
- neomycin
- streptomycin
- polymyxin B
- bovine serum albumin
For Product Information and Consumer Medicine Information about IPOL visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed